lomerizine has been researched along with Depressive Disorder, Major in 1 studies
lomerizine: used to treat migraines
Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kawamura, S | 1 |
Sakai, A | 1 |
Endo, T | 1 |
Maruta, M | 1 |
1 other study available for lomerizine and Depressive Disorder, Major
Article | Year |
---|---|
Atypical depression as a premonitory symptom of migraine managed by an oral contraceptive.
Topics: Adult; Alprazolam; Borderline Personality Disorder; Calcium Channel Blockers; Contraceptives, Oral, | 2008 |